TG Therapeutics Inc. (TGTX)

5.00
0.15 2.90
NASDAQ : Health Technology
Prev Close 5.15
Open 5.25
Day Low/High 5.00 / 5.35
52 Wk Low/High 5.10 / 17.35
Volume 2.05M
Avg Volume 1.05M
Exchange NASDAQ
Shares Outstanding 82.82M
Market Cap 766.08M
EPS -1.90
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

First Week Of January 2021 Options Trading For TG Therapeutics (TGTX)

First Week Of January 2021 Options Trading For TG Therapeutics (TGTX)

Investors in TG Therapeutics Inc saw new options become available this week, for the January 2021 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 850 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

TG Therapeutics Is Now Oversold (TGTX)

TG Therapeutics Is Now Oversold (TGTX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

How I See Biotechs Now

How I See Biotechs Now

I expect deal volume to have a substantial uptick before the end of 2018 rolls around.

First Week Of TGTX October 19th Options Trading

First Week Of TGTX October 19th Options Trading

Investors in TG Therapeutics Inc saw new options begin trading this week, for the October 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the TGTX options chain for the new October 19th contracts and identified one put and one call contract of particular interest.

TGTX September 21st Options Begin Trading

TGTX September 21st Options Begin Trading

Investors in TG Therapeutics Inc saw new options begin trading today, for the September 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the TGTX options chain for the new September 21st contracts and identified one put and one call contract of particular interest.

Notable Two Hundred Day Moving Average Cross - TGTX

Notable Two Hundred Day Moving Average Cross - TGTX

In trading on Wednesday, shares of TG Therapeutics Inc crossed below their 200 day moving average of $11.84, changing hands as low as $11.50 per share. TG Therapeutics Inc shares are currently trading off about 2.7% on the day.

First Week Of July 20th Options Trading For TG Therapeutics (TGTX)

Investors in TG Therapeutics Inc saw new options become available this week, for the July 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the TGTX options chain for the new July 20th contracts and identified one put and one call contract of particular interest.

Relative Strength Alert For TG Therapeutics

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

First Week Of June 15th Options Trading For TG Therapeutics (TGTX)

Investors in TG Therapeutics Inc saw new options begin trading this week, for the June 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the TGTX options chain for the new June 15th contracts and identified one put and one call contract of particular interest.

TG Therapeutics, Inc. To Present At The Needham 17th Annual Healthcare Conference

TG Therapeutics, Inc. To Present At The Needham 17th Annual Healthcare Conference

Presentation scheduled for Wednesday, March 28, 2018 at 4:00pm ET

Tuesday Investor Blog: Is the Bull Market in Stocks Being Ripped to Shreds?

Tuesday Investor Blog: Is the Bull Market in Stocks Being Ripped to Shreds?

Bring your A-game in these markets or go home. Just keeping it real. Here is what you need to know on Tuesday.

15 Biotech Firms That Have Strong Potential to Be Acquired: Jefferies

15 Biotech Firms That Have Strong Potential to Be Acquired: Jefferies

'Balance sheets are flush with cash and there is a need to grow for large health care companies,' Jefferies analysts wrote.

TG Therapeutics, Inc. Announces Fourth Quarter And Year-End 2017 Financial Results And Business Update

TG Therapeutics, Inc. Announces Fourth Quarter And Year-End 2017 Financial Results And Business Update

Investor conference call to be held today, Thursday March 8, 2018 at 8:30am ET  

TG Therapeutics, Inc. To Host Conference Call On Fourth Quarter And Year-End 2017 Financial Results And Business Update

TG Therapeutics, Inc. To Host Conference Call On Fourth Quarter And Year-End 2017 Financial Results And Business Update

Investor Conference Call to be held Thursday, March 8, 2018 at 8:30am ET  

First Week of April 20th Options Trading For TG Therapeutics (TGTX)

First Week of April 20th Options Trading For TG Therapeutics (TGTX)

Investors in TG Therapeutics Inc saw new options become available this week, for the April 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the TGTX options chain for the new April 20th contracts and identified one put and one call contract of particular interest.

TG Therapeutics, Texas Instruments, ConocoPhillips: 'Mad Money' Lightning Round

TG Therapeutics, Texas Instruments, ConocoPhillips: 'Mad Money' Lightning Round

Jim Cramer spotlights TG Therapeutics, Texas Instruments, ConocoPhillips, SemGroup, and Energous.

Just Wait For It: Cramer's 'Mad Money' Recap (Tuesday 2/27/18)

Just Wait For It: Cramer's 'Mad Money' Recap (Tuesday 2/27/18)

Jim Cramer says that sometimes, you just have to sit back and wait for more compelling buying opportunities.

These 2 Biotech Stocks Still Have Upside

These 2 Biotech Stocks Still Have Upside

The biotech sector has seen a big rally, but there are still opportunities.

First Week of TGTX February 16th Options Trading

First Week of TGTX February 16th Options Trading

Investors in TG Therapeutics Inc saw new options begin trading this week, for the February 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the TGTX options chain for the new February 16th contracts and identified one put and one call contract of particular interest.

Why 2018 Will Be Better for Biotech Deals Than 2017

Why 2018 Will Be Better for Biotech Deals Than 2017

Analysts see a year of robust deal action ahead due in part to clarity from a tax standpoint.

TG Therapeutics, Inc. To Present At The 36th Annual J.P. Morgan Healthcare Conference

TG Therapeutics, Inc. To Present At The 36th Annual J.P. Morgan Healthcare Conference

Presentation Scheduled for Thursday, January 11, 2018 at 7:30am PT

Interesting TGTX Put And Call Options For August 2018

Interesting TGTX Put And Call Options For August 2018

Investors in TG Therapeutics Inc saw new options begin trading this week, for the August 2018 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 231 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

TheStreet Quant Rating: D- (Sell)